Aug 2026· Automation· Vol 7, pp. 128· 0 citations· 76 references
TL;DR
The proposed fuzzy-control framework offers a promising automation-based strategy for resilient glucose regulation under uncertainty, measurement imperfections, and actuation delays, and the robustness of the proposed automated control framework is evaluated under challenging operating conditions.
Abstract
Type I diabetes mellitus (T1DM) is a chronic metabolic disease resulting from insufficient insulin secretion into the bloodstream‚ causing elevated blood glucose concentrations to dangerous levels․ Automated regulation of blood glucose levels in T1DM can be modeled as a nonlinear‚ uncertain‚ and disturbance-affected closed-loop control process with a time delay‚ time-varying insulin sensitivity, and imperfect glucose measurements. This paper presents the design, multi-objective tuning, and robustness evaluation of a fuzzy logic controller (FLC) for automated insulin-infusion regulation. The proposed FLC uses the glucose tracking error and its time derivative as feedback signals to determine the required insulin control action and maintain glucose within the desired range of (70–160 mg/dL). The controller parameters are optimized using the Non-Dominated Sorting Genetic Algorithm II (NSGA-II) to address three competing control objectives: minimizing hypoglycemia risk, minimizing hyperglycemia risk, and reducing total insulin usage. The resulting Pareto-optimal solutions provide a set of trade-off controller designs for decision-makers based on safety, performance, and insulin-efficiency requirements. The robustness of the proposed automated control framework is evaluated under challenging operating conditions, including elevated initial glucose levels, model-parameter uncertainties, external disturbances, variations in insulin sensitivity, distorted glucose measurements, and delayed insulin infusion. A comparative study with a linear quadratic regulator-based controller (LQRC) is conducted as a benchmark. Simulation results demonstrate that the optimized FLC provides superior closed-loop performance and stronger robustness than the LQRC across all tested scenarios. The proposed fuzzy-control framework, therefore, offers a promising automation-based strategy for resilient glucose regulation under uncertainty, measurement imperfections, and actuation delays.
Type-I Diabetes Mellitus (TIDM) is characterized by
autoimmune destruction of pancreatic β-cells, resulting in absolute insulin deficiency and
impaired glucose regulation. Maintaining normoglycemia is challenging due to the nonlinear and
time-varying nature of Glucose–Insulin (GI) dynamics, meal disturbances, and p...
A. Patra, Smitta Ranjan Dutta, Anuja Nanda· Current Science, Engineering...· 0 citations
Effective blood glucose regulation in individuals with Type 1 diabetes remains a challenging control problem due to strong nonlinearities, inter-patient variability, and unmodeled disturbances such as physical activity. Exercise introduces rapid and highly uncertain changes in insulin sensitivity, often leading to hypo...
Priyanka Thakur, Yrithu T. Pillay, John Watkins et al.· Conference on Control Techno...· 0 citations
A mathematical model of Type 2 Diabetes Mellitus is developed in this paper, by which the dynamics of the disease can be predicted with the aid of the related extracted ordinary differential equations. The important biological factors, including physical activities and insulin sensitivity, are considered in modeling th...
D. Kiaei, H. Tourajizadeh, Behnam Miripour Fard· Proceedings of the Instituti...· 0 citations
An artificial pancreas (AP) is a biomedical device that mimics the natural glucose-regulation process carried out by a healthy pancreas. This device consists of three parts: a continuous glucose monitor (CGM), a control algorithm, and an insulin pump. These three parts work together by continuously monitoring blood glu...
L. T. Rasheed, A. Alaraji, T. Mohammadridha· Iraqi Journal of Computers,...· 0 citations
Type 1 diabetes mellitus is one of the most complex chronic metabolic disorders, significantly impacting both patients' quality of life and global healthcare systems. The condition is characterized by the autoimmune destruction of pancreatic β-cells, rendering the body unable to synthesize endogenous insulin. Consequen...
D. Arotaritei, Ilea Mihail-ovidiu· World Wide Journal of Multid...· 0 citations
Closed-loop insulin delivery, or the artificial pancreas, has evolved from an ambitious engineering concept into one of the most consequential advances in diabetes technology. By integrating continuous glucose monitoring, insulin pumps, and control algorithms into a single feedback system, these platforms aim to shift...
R. E. Al-Dhaleai, Mustafa Tariq Khan, Zaid Chilmeran et al.· Biosensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.